Interested in receiving more information about our publications? Don't hesitate to contact our clinical team via clinical@fibricheck.com!
- FibriCheck algorithm
- AF detection in patients without prior AF diagnosis
- Managing diagnosed AF patients
- FibriCheck PPG readability
- Usability
- Other
FibriCheck algorithm
Title | Year | Objective | Key message(s) |
---|---|---|---|
Comparative evaluation of consumer wearable devices for atrial fibrillation detection: A validation study | 2024 |
To evaluate and compare the ability of CWDs to discriminate between sinus rhythm and AF. |
In this selected population, the discrimination between sinus rhythm and AF using CWDs based on ECG or PPG was highly accurate, with no discernible variations across the examined devices. |
Real-world validation of smartphone-based photoplethysmography for rate and rhythm monitoring in atrial fibrillation |
2024 |
Photoplethysmography- (PPG) based smartphone applications facilitate heart rate and rhythm monitoring in patients with paroxysmal and persistent atrial fibrillation (AF). Despite an endorsement from the European Heart Rhythm Association, validation studies in this setting are lacking. Therefore, we evaluated the accuracy of PPG-derived heart rate and rhythm classification in subjects with an established diagnosis of AF in unsupervised real-world conditions. |
Smartphone applications using PPG can be used to monitor patients with AF in unsupervised real-world conditions. The accuracy of AF detection algorithms in this setting is excellent, but PPG-derived heart rate may tend to underestimate higher heart rates. |
Accuracy of continuous photoplethysmography-based heart rate assessment during atrial fibrillation | 2023 |
Although mobile health tools using photoplethysmography (PPG) technology have been validated for the detection of atrial fibrillation (AF), their utility for heart rate assessment during AF remains unclear. Therefore, we aimed to evaluate the accuracy of continuous PPG-based heart rate assessment during AF. |
During persistent AF, continuous PPG-based heart rate assessment is feasible and shows high accuracy compared to Holter ECG. Motion and recording quality among other PPG-derived covariates did not introduce a systematic and correctable bias in the heart rate assessment. |
2023 | The aim of this study was to assess the accuracy of a well-known standalone PPG-AF detection algorithm added to a popular wristband and smartwatch, with regard to discriminating AF and sinus rhythm, in a group of patients with AF before and after cardioversion (CV). | This study demonstrates that the addition of a well-known standalone PPG-AF detection algorithm to a popular PPG smartwatch and wristband without integrated algorithm yields a high accuracy for the detection of AF, with an acceptable unclassifiable rate, in a semicontrolled environment. | |
Accuracy of continuous photoplethysmography-based 1 min mean heart rate assessment during atrial fibrillation | 2023 | To evaluate the accuracy of continuous PPG-based 1 min mean heart rate assessment during AF compared with Holter ECG monitoring as a reference and establish predictors for an accurate PPG-based 1 min mean heart rate assessment in patients with persistent AF |
Continuous PPG-based 1 min mean heart rate assessment during AF seems feasible to guide a lenient rate control and shows good accuracy compared with Holter ECG as a reference Future studies need to be performed to evaluate how to integrate PPG-derived heart rate information into clinical decision-making processes to guide rate control in patients with AF Motion and recording quality among other PPG-derived covariates did not introduce a systematic and correctable bias in the 1 min mean heart rate assessment Chronic heart failure was associated with lower accuracy of the PPG-based 1 min mean heart rate assessment |
Assessment of heart rate agreement on continuous photoplethysmography monitoring using a smartwatch versus beat-to-beat synchronized ECG monitoring | 2021 | To assess the agreement between continuous PPG monitoring using a smartwatch and continuous ECG Holter monitoring in the identification of heartbeats and calculation of the HR | The AI algorithm analyzing continuous out-of-hospital PPG tracings can annotate heartbeats and assess HR without a clinically significant bias compared to continuous ECG monitoring, both during AF and non-AF rhythms in a heterogeneous patient population |
Evaluation of the device independent nature of a photoplethysmography-deriving smartphone app | 2021 | To study the device independency of AF detection performance by a PPG-based smartphone application | The sensitivity and specificity of the AF detection algorithm ranged from 90.9% to 100.0% and 94.5% to 100.0%, respectively. Head-to-head comparisons of the results did not reveal significant differences in sensitivity or specificity of the proprietary AF detection algorithm among the different devices |
Head-to-head comparison of proprietary PPG and single-lead ECG algorithms for atrial fibrillation detection | 2021 | To evaluate and compare the diagnostic performance of a PPG-deriving smartphone app and a single-lead ECG-deriving hand-held device for AF detection | Results demonstrated a 96.4% accuracy for PPG and 94.1% for single-lead ECG. No significant differences in sensitivity (P = 0.453) or specificity (P = 0.219) between the proprietary PPG and single-lead ECG algorithms were found. This study demonstrated equivalent diagnostic performance of PPG and single-lead ECG proprietary AF detection algorithms in smartphone apps |
Performance of an artificial intelligence algorithm to detect atrial fibrillation on a 24-hour continuous photoplethysmography recording using a smartwatch: ACURATE study | 2021 | To determine the diagnostic performance of an artificial intelligence algorithm to detect AF using photoplethysmography acquired by a smartwatch. | Continuous out-of-hospital PPG monitoring using a smart-watch in combination with an AI algorithm can accurately discriminate between AF and non-AF rhythms in a heterogeneous patient population. PPG quality is more often affected than ECG quality during daily life activities |
Assessment of a standalone photoplethysmography (PPG) algorithm for detection of atrial fibrillation on wristband-derived data | 2020 | The use of the Fibricheck algorithm on wristband derived-data has never been studied. Present study aims to evaluate the standalone Fibricheck algorithm using wristband-derived data with regard to diagnosing AF in small real-world cohort of mostly elderly people. | AF detection by the Fibricheck standalone algorithm is feasible and has a high sensitivity and specificity in a small real-world cohort. It shows comparable results to the use of a one-lead ECG wristband. The results of this study encourage further development of PPG-AF algorithms in combination with wristbands by demonstrating high diagnostic accuracy and acceptable unclassifiable quality rate. |
Mobile Phone–Based Use of the Photoplethysmography Technique to Detect Atrial Fibrillation in Primary Care- Diagnostic Accuracy Study of the FibriCheck App | 2019 | To test the diagnostic accuracy of such an approach using the FibriCheck mobile phone app (Qompium) in comparison with the gold standard method of AF diagnosis, the 12-lead ECG | Cardiac rhythm analysis through a mobile phone–based PPG signal with the FibriCheck AF algorithm had very good sensitivity and specificity to detect AF. False-positive results were mainly because of the presence of extrasystoles. The FibriCheck AF algorithm accurately diagnosed AF on the basis of a single-lead ECG, with a similar sensitivity and specificity compared with the PPG signal. Beat-to-beat analysis showed a strong agreement between the PPG and the single-lead ECG signal. The patient does not require any experience or medical education and can be easily trained to use the app. Physicians can remotely review the transferred data, which enables optimal patient follow-up in a less time-consuming manner. |
2019 | This study evaluated the diagnostic accuracy of a PPG-based pulse-deriving smartphone application with respect to handheld single-lead ECG and 12-lead ECG. In addition, the device dependent nature and robustness of the performance of the application was assessed. | The diagnostic accuracy of the pulse-deriving smartphone application and the handheld single-lead ECG device was strongly influenced by the presence of regular atrial flutters, stressing the importance of further thorough validation. For the pulse-deriving smartphone application, there was no significant influence from device type in terms of diagnostic accuracy for the detection of AF. Insufficient quality measurements were more frequently performed on Android devices. | |
Evaluation of screening technologies and assessments in a voluntary screening programme in the general belgian population | 2018 | Screening for AF has been proposed as a way of reducing the burden of the disease by offering the possibility to timely initiate anticoagulation therapy. This study was organised to assess the efficacy and feasibility of a nationwide voluntary screening program in the Belgian general population over 40 years of age. | A dual assessment was made in this study: aiming for maximum sensitivity (AF + other arrhythmias) versus maximum specificity (normal+ other arrhythmia). AF was present in 0.5% of the participants. All AF-patients had an increased stroke risk. The present study shows that a voluntary screening programme using high accuracy PPG-based and single-lead ECG tools was able to detect an important number of patients with previously undetected AF. |
Using smartphone enabled technologies for detection atrial fibrillation- is there a difference in signal quality between ECG and PPG | 2018 | This work focuses on comparing the performance between photoplethysmography (PPG) and single lead ECG based smartphone applications during a national incentivized screening initiative and evaluate the quality related issues between these technologies. | Detection of pulse intervals based on PPG is a sensitive and accurate screening tool for the detection of atrial fibrillation and has a high level of agreement with the results obtained using the single lead ECG. Despite the quality challenges of PPG signals, there is no correlation found in the cause nor the agreement between both technologies indicating that for the general population the quality parameters are properly tuned to prevent misdiagnosis as much as possible. These quality parameters will be a fundamental requirement to further leverage PPG signals as a suitable signal for heart rhythm analysis. |
Clinical Validation of Heart Rate Apps- Mixed-Methods Evaluation Study | 2017 | To investigate and describe the necessary elements in validating and comparing HR apps versus standard technology. To investigate the correct method that should be used to clinically validate smartphone apps that measure HR, the smartphone app FibriCheck was used as a test case. | The most suitable method for the validation of an HR app is a simultaneous measurement of the HR by the smartphone app and an ECG system and comparing the obtained intervals. This approach could lead to almost exact accuracy in the clinical setting. |
Evaluating smartphone based photoplethysmography as a screening solution for atrial fibrillation: a digital tool to detect AF? | 2017 | This work focuses on comparing the feasibility, sensitivity and accuracy of photoplethysmography (PPG) and single lead-ECG based smartphone applications for the diagnosis of AF during a national incentivized screening campaign in the community. | The obtained results indicate that detection of pulse intervals based on PPG is a feasible, sensitive and accurate screening tool for the detection of AF with a high level of agreement when compared to the results obtained using the single lead ECG. The use of a smartphone-only application could unlock the potential of digital screening and support case finding in selected populations at risk for AF. |
PPG versus single lead ECG for the diagnose of Atrial Fibrillation | 2017 | Diagnosis of AF, based on the visual interpretation of a PPG-signal results in a high clinical accuracy compared to single-lead ECGs and the current gold 12-lead ECG-standard | The use of a smartphone application for AF patients results in a good accuracy for diagnosis. Possible problems could arise concerning education and training for cardiologists. After enabling data-analysis, sensitivity and specificity rates increase to a very high accuracy corresponding to the 12-lead gold standard ECG. Algorithms could be important to process PPG measurements to adjust the quality of the data. |
Validation of a new smartphone application (“FibriCheck”) for the diagnosis of atrial fibrillation in primary care | 2017 | To investigate the diagnostic accuracy of the FibriCheck app in a convenience sample of patients aged 65 and older in general practice. | The FibriCheck algorithm was able to accurately diagnose AF based on the obtained single-lead ECG with a high sensitivity and specificity. The application scored an equally high sensitivity, but a slightly lower specificity when measuring and interpreting the PPG signal. The high sensitivity of the application reflects the good capacity of the algorithm to rule out AF. False positive results were mainly due to the presence of extra systoles and low signal quality that remained undetected by the filter. The main advantages of the app are that it is a quick, cheap and practical measurement method without the need for special infrastructure or any external hardware. A disadvantage was the number of false positive results ,due to atrial or ventricular extrasystoles, a known AF screening issue using RR-interval variability analysis. |
Screening for atrial fibrillation using only a smartphone application - a new tool to unlock digital screening | 2016 | The performance evaluation of using a smartphone application FibriCheckas a screening tool for Atrial Fibrillation, for identifying cases of untreated, frequently asymptomatic AF. | The FibriCheck application had a sensitivity of 100% and a specificity of 95.8% for the detection of atrial fibrillation. No correlation was found between the cases with bad quality measurements for both measurement techniques. The obtained results indicate that detection of pulse intervals based on PPG is a sensitive and accurate screening tool for the detection of atrial fibrillation and has a high level of agreement with the results obtained using the single lead ECG. The use of a smartphone-only application could unlock the potential of digital screening and support case finding of atrial fibrillation in selected populations at risk for atrial fibrillation. |
“Smart” solutions for paroxysmal atrial fibrillation | 2016 | A 66-year-old female patient who was implanted with an implant-able loop recorder (ILR) due to a history of unexplained syncope and symptoms of palpitations. After the procedure, the patient received a smartwatch device to measure the PPG signal at the wrist | After synchronizing the data streams between the ILR, smartwatch, and smartphone, all AF events that occurred while wearing or using one of the smart devices were picked-up and identified as AF by the in-house-developed algorithms. Persuasive technologies such as smartphones and smartwatches can provide a new potential in the detection and management of patients with AF. |
Validation of a smartphone based photoplethysmographic beat detection algorithm for normal and ectopic complexes | 2014 | A smartphone based acquisition and processing algorithm was developed to collect PPG data in a controlled hospital environment. The aim is to identify the presence of premature, atrial ectopic beats using only a smartphone. | It is possible to do more with the PPG collected with a smartphone camera than currently being done by popular heart rate apps. Beside the heart rate measurement of a sinus rhythm, the presence of premature atrial ectopic beats can also be detected based on the observation of the resulting compensatory pause. The designed algorithm for this research was sufficient for the most datasets but needs more work to be made robust for future studies and field testing |
AF detection in patients without prior AF diagnosis
AF detection in high risk patients: around stroke
Title | Year | Objective | Key Messages |
---|---|---|---|
The use of smartphone app to detect atrial fibrillation (AF) after cryptogenic stroke |
2024 | The aim of this study is to evaluate the feasibility of a photopletsymography (PPG)-based smartphone app for AF detection after cryptogenic stroke. | The use of a PPG-based smartphone app for AF detection after an acute stroke is feasible, with moderate agreement to current conventional forms of heart rhythm monitoring. PPG may be a more cost-effective alternative for rhythm management after stroke. |
The Potential and Limitations of Mobile Health and Insertable Cardiac Monitors in the Detection of Atrial Fibrillation in Cryptogenic Stroke Patients: Preliminary Results From the REMOTE Trial | 2022 | To explore the opportunities and hurdles of using insertable cardiac monitors and PPG-based mHealth using a smartphone or smartwatch to detect AF in cryptogenic stroke and transient ischemic attack patients. | mHealth was able to detect AF in a patient in which AF was confirmed on the ICM Even state-of-the-art ICMs yielded many false-positive AF registrations Both mHealth and ICM still require physician revision Blinding of the mHealth results impairs compliance and motivation. |
Will Smartphone Applications Replace the Insertable Cardiac Monitor in the Detection of Atrial Fibrillation? The First Comparison in a Case Report of a Cryptogenic Stroke Patient | 2022 | To investigates the added value of PPG-based mobile health in AF detection using spot-check and semi-continuous measurements on the smartphone or smartwatch, respectively. | First report of the cryptogenic stroke patient in whom PPG-based mHealth was able to detect occurrence and burden of paroxysmal AF episodes with similar precision as ICM. ICM is the most performant rhythm monitoring device but is expensive, invasive, and currently underutilized. This case demonstrated the feasibility of implementing PPG-based mHealth monitoring as a low-cost and non-invasive tool. |
The use of a photoplethysmography- deriving smartphone app to screen for atrial fibrillation in primary stroke prevention during the covid pandemic | 2022 | The aim of this study is to assess the use of a PPG-deriving smartphone-app for early detection of AF and initiation of appropriate treatment to prevent AF-related complications, like stroke. | PPG-deriving technologies enable remote AF-detection and may contribute to timely initiation of appropriate treatments to prevent complications. One of the major advantages of this approach is the fact that physicians are able to remotely screen and follow-up at risk without the need for face-to-face contacts. |
Health economic assessment of smartphone implementation for atrial fibrillation monitoring in cryptogenic stroke patients | 2020 | To address long-term cost-effectiveness of prolonged monitoring by implementing a smartphone application for AF monitoring in post-cryptogenic stroke patients and assessing its cost-effectiveness. | After a cryptogenic stroke, 3-month FibriCheck monitoring proved to be cost-effective for preventing recurrent strokes. These results strengthen the evidence base for prolonged monitoring in secondary stroke prevention. The implementation of FibriCheck in a population of 1000 patients resulted in 26 quality adjusted life years (QALY) and substantial cost savings of -1.189 €/QALY |
Implementation of a pulsederiving smartphone application in high risk populations for primary and secondary prevention of stroke | 2019 | This multi centre national study addresses the implementation and evaluation of a pulsederiving smartphone application in highrisk patient populations as a solution for primary and secondary stroke prevention. The study was performed for the Cabinet of Minister of Health De Block and the National Institute for Health and Disability Insurance (RIZIV). | This study presents the first results of prolonged PPG monitoring in high risk populations for AF detection. Considering the high number of asymptomatic registrations, repeated PPG spotchecks proved to be valuable for the detection of new or recurrent, (a)symptomatic, paroxysmal or persistent AF. |
AF detection in high risk patients: increased risk score
Title | Year | Objective | Key Messages |
---|---|---|---|
MVP Risk score and new atrial fibrillation diagnosis: Prospective cohort PREFATE study |
2024 |
To assess the association between ECG patterns according to the MVP ECG risk score (morphology-voltage-P-wave duration) and a diagnosis of AF. |
The diagnosis of AF was confirmed in 14 cases (9.3%, 95% CI 5.6-15.1), 3 men and 11 women. In 3 cases, the arrhythmia was diagnosed on the baseline ECG, and in 11 cases by Holter after being reported as possible AF by the FibriCheck App. A higher prevalence of atypical advanced interatrial block (A-AIB) (p 0.007) was detected among participants with AF, as well as the prevalence of P-wave < 0.1 mV. (p = 0.006). All new diagnoses of AF were made at scores ≥ 4 in the MVP risk score. |
Feasibility and diagnostic yield of a photoplethysmography-based arrhythmia screening and integrated management pathway in a chronic obstructive pulmonary disease outpatient clinic | 2024 | We aimed to assess the feasibility and yield of a photoplethysmography (PPG) smartphone app-based pathway for AF detection within a COPD outpatient clinic. | 14-days opportunistic PPG app-based screening is feasible in COPD outpatient care and results in the detection of new AF cases and premature beats. This novel digital approach offers a practical method to implement recommended AF screening in COPD patients. |
Remote heart rhythm assessment using smartphone-based photoplethysmography in primary care to detect undiagnosed atrial fibrillation in patients with chronic obstructive pulmonary disease | 2023 | The goal of this study was to evaluate the accuracy and effectiveness of a smartphone-based photoplethysmography (PPG) technology to enable remote heart rhythm monitoring and new AF detection in patients with COPD. | Remote heart rhythm assessment using smartphone-based PPG in primary care within a COPD population was feasible and resulted in the detection of newly diagnosed AF in COPD patients. All patients identified with possible AF based on PPG monitoring were confirmed and diagnosed via ECG which enabled the initiation of guideline-based AF management. |
Implementing an end-to-end pathway for detection, diagnosis, and management of atrial fibrillation in the risk-stratified patients: results from the atrial fibrillation stroke prevention hub program | 2023 | This program aimed to establish an end-to-end pathway to identify, detect, diagnose, and manage high-risk patients with no prior AF diagnosis. | Compared to the current NHS opportunistic pulse check, where the detection rate is <1%, the AF Stroke Prevention Hub program successfully identified patients with a significantly higher detection rate. The hub delivered an end-to-end pathway allowing real-time reporting and triaging of patients, early detection, appropriate confirmation, and rapid treatment with favorable real-life technology adoption. Expanding the data-driven program to a wider difficult-to-reach population could reduce the burden on NHS and improve patient outcomes. |
Self-Reported Mobile Health-Based Risk Factor and CHA2DS2-VASc-Score Assessment in Patients With Atrial Fibrillation: TeleCheck-AF Results |
2022 |
To evaluate the feasibility and accuracy of a remote mobile app-based self-reported assessment of AF risk factors and CHA2DS2-VASc-score, with the help of a 10-item questionnaire | Collection of AF-risk factors by an app-based 10-item questionnaire is feasible, even despite the age of participants. High accuracy of pacemaker and anticoagulation treatment assessment. Limited accuracy for the assessment of some of the traditional AF risk factors as components of the CHA2DS2-VASc-score. Whether app-based risk factor assessment can be incorporated in personalized patient education and longitudinal guidance of risk factor modification programs requires future studies. |
The effect of a case-finding app on the detection rate of atrial fibrillation compared with opportunistic screening in primary care patients: protocol for a cluster randomized trial | 2021 | Implementing the FibriCheck app in a primary care setting could solve the problem of screening for AF and, specifically, detecting PAF. the aim of this study is to investigate the effect of a case-finding strategy with the FibriCheck application on the detection rate of AF in comparison with opportunistic screening (i.e. pulse palpation, followed by an ECG) in patients with ahigh risk of AF in general practice. The secondary objective is to keep track of thrombo-embolic complications, death and compliance with measurements. | This will be the first study to evaluate the influence of a stand-alone smartphone application on the detection rate of AF compared to a control group. The availability of correctly coded data is essential for the study to be conducted. Physicians must code diligently and completely. To screen high-risk patients, we will use the sufficiently validated CHARGE-AF score. A screening period of 4 weeks will provide sufficient diagnostic yield. Possible limitations to the study are a sufficient working internet connection and patient compliance. |
Evaluation of the feasibility and accuracy of remote mobile app-based self-reported atrial fibrillation risk factor assessment in patients with atrial fibrillation: TeleCheck-AF results | 2021 | To evaluate the feasibility and accuracy of remote mobile app-based self-reported AF risk factor assessment in AF patients | Patient self-reported AF risk factors by a remote mobile app-based assessment is feasible and may be useful for future digital trials and comprehensive remote AF management through teleconsultation |
AF detection in high risk patients: post-cardiac surgery
Title | Year | Objective | Key Messages |
---|---|---|---|
Impact of photoplethysmography-based smartphone rhythm monitoring on atrial fibrillation detection and management after cardiac surgery: a pragmatic randomized trial | 2024 |
To determine whether intermittent PPG-based smartphone rhythm monitoring, after being discharged home following cardiac surgery, impacts AF management. |
In unselected patients discharged home following cardiac surgery, PPG-based smartphone monitoring revealed significantly more POAF which led to changes in AF management (OAC initiation, rhythm control therapy or CIED insertion). Longer follow-up is needed to determine whether these changes will lead to improved outcomes. |
Remote Heart Rhythm Monitoring by Photoplethysmography-Based Smartphone Technology After Cardiac Surgery - Prospective Observational Study | 2021 | By using a PPG-based smartphone app, we aimed to gain more insight into the prevalence of AF and other rhythm-related complications upon discharge home after cardiac surgery and evaluate the implementation of this app into routine clinical care | Implementation of smartphone-based PPG technology enables detection of AF and other rhythm-related complications after cardiac surgery. An association between AF detection and an underlying complication was found in 2 patients. Smartphone-based PPG technology may supplement rehabilitation after cardiac surgery by acting as a sentinel for underlying complications, rhythm-related or otherwise. |
AF detection: untargeted
Title | Year | Objective | Key Message(s) |
---|---|---|---|
Smartphone-based atrial fibrillation screening in the general population: feasibility and impact on medical treatment | 2023 |
To determine the feasibility, detection rate and therapeutic implications of large-scale smartphone-based screening for Atrial Fibrillation (AF). |
Smartphone-based AF screening is feasible at large scale. Screening increased OAC uptake and impacted therapy of both new and previously diagnosed clinical AF, but failed to impact risk factor management in subjects with subclinical AF. |
Smartphone-Based Screening for Atrial Fibrillation – Experiences from Bosnia and Herzegovina |
2022 | To examine the prevalence of AF and the effectiveness of photoplethysmography (PPG) deriving smartphone app in Bosnia and Herzegovina. | The use of smartphone-based technologies for the detection of AF has proven to be an effective way of screening the population for this heart rhythm, as all patients with a positive result based on the 7-day screening were confirmed via the 24-hour Holter ECG. Although this is a small pilot study, the results indicate that the number of patients with AF is higher in relation to available statistical data and date from everyday medical practice. Therefore, it is necessary to develop a good strategy for early AF screening to prevent adverse outcomes such as stroke but also other cardiovascular complications. |
Atrial fibrillation screening with photo-plethysmography through a smartphone camera | 2019 | Small studies on PPG-based screening for AF have already demonstrated excellent sensitivity of 100%with an acceptable specificity of 90–97% against the 12-lead ECG as gold standard. The current study was set up to assess the feasibility of mass screening for AF through a smartphone-based algorithm using PPG technology by the only CE approved application that has been recently developed |
Data from this study strongly suggest that more intensive screening for AF is associated with a substantially higher diagnostic yield. |
Managing diagnosed AF patients
Title | Year | Objective | Key Message(s) |
---|---|---|---|
Effectiveness of photoplethysmography-based rhythm monitoring after atrial fibrillation ablation using a smartphone application | 2024 |
To compare the effectiveness of digital follow-up utilizing a PPG-based smartphone application with conventional ECG-based follow-up for the detection of atrial arrhythmia recurrence after ablation. |
Among patients with AF ablation, digital PPG-based rhythm monitoring with a smartphone, was non-inferior in the detection of atrial arrhythmia recurrence after ablation. Moreover, the detection of atrial arrhythmia was significantly increased compared to conventional ECG-based monitoring. |
Remote Rhythm Monitoring using a Photoplethysmography Smartphone Application after Cardioversion for Atrial Fibrillation | 2024 |
Direct current cardioversion (DCCV) is a commonly utilised rhythm control technique for atrial fibrillation (AF). Follow-up typically comprises a hospital visit for 12-lead ECG two weeks post-DCCV. We report the feasibility, costs and environmental benefit of remote photoplethysmography (PPG) monitoring as an alternative. |
Remote PPG monitoring is a viable method of assessing for arrhythmia recurrence post-DCCV. This approach may save patients significant travel time, reduce environmental CO2 emission and be cost saving in a publicly-funded healthcare system.
|
Insights from a single centre implementation of a digitally-enabled atrial fibrillation virtual ward | 2024 |
To provide insights into the promise of integrating digital health and remote monitoring into AF management via a virtual ward model. |
This study indicates that the virtual ward model enabled patients to be effectively triaged remotely, allowed health deteriorations to be recognised early, ensuring patients received timely medical attention or emergency care, and reduced the likelihood of subsequent ED reattendances on discharge. It also demonstrates the potential cost effectiveness of the model through readmission avoidance and early supported discharge of stable hospitalised AF patients, who might otherwise have had a longer inpatient stay. This pilot study provides valuable insights into the promise of integrating digital health and remote monitoring into AF management via a virtual ward model. |
Changes in healthcare utilisation during implementation of remote atrial fibrillation management: TeleCheck-AF project | 2024 |
To evaluate changes in healthcare utilisation and comprehensive packages of care activities and procedures (referred in the Netherlands to as ‘diagnose-behandelcombinatie (DBC) care products) during the implementation of the TeleCheck-AF approach (teleconsultation supported by app-based heart rate/rhythm monitoring) in a Dutch atrial fibrillation (AF) clinic. |
The implementation of TeleCheck-AF was associated with a change in health care utilisation and a disproportional decrease in reimbursement by health insurers due to a change from medium-weight to light-weight DBC care products. Its implementation decreased the potential burden on patients caused by, for example, travel costs and time investment. These results were used as the basis for the development of a new optional reimbursement code for the TeleCheck-AF approach in the Netherlands. This example can serve as a roadmap for future development of digital AF care reimbursement models in the Netherlands and worldwide. |
Prolonged photoplethysmography-based heart rhythm monitoring in patients undergoing re-ablation of atrial fibrillation - compliance, motivation, and experience | 2023 |
Technical advances in photoplethysmography (PPG) utilizing smartphones have led to the capability of domestic heart rhythm monitoring (HRM). Longitudinal HRM after catheter ablation of atrial fibrillation (AF) may increase the detection rate of AF relapses and improve patient care. However, there is only limited evidence on patients’ motivation, compliance, and experience. |
Our data show excellent compliance and good motivation as well as good experience with a prolonged smartphone-based HRM in the setting of re-ablation of AF showcasing patients willingness to actively take part in their own care process. This suggests that current standard of care after catheter ablation of AF should be complemented by more intensive HRM involving telemedical approaches. |
Transforming our post-atrial fibrillation ablation follow up patient pathway using FibriCheck: A smartphone digital app used for remote monitoring |
2023 |
To determine if the validated smartphone application |
Using FibriCheck, 12-lead ECGs and Holters were avoided, reducing the burden on primary care, and releasing Holter monitors to patients with higher acuity. This also equated to significant cost |
Developing & implementing a digital care pathway for patients with AF using remote monitoring. |
2023 |
To digitize and enhance pre-existing AF care pathways through implementation of an early supported discharge pathway, using an approach that leverages digital remote monitoring technologies. Two digital elements were integrated, being FibriCheck and a digital interface, integrated with the patient electronic health record. A remote monitoring hub, staffed by trained specialist nurses, managed the virtual AF ward environment and conducted telephone triage assessments, escalating to the cardiology team when needed. |
Patients can be triaged safely and effectively in virtual AF wards. Out of the patients enrolled, there was 95% patient engagement with remote monitoring with positive patient feedback overall. This approach led to a 4-day shorter length of stay with reduction in rates of rehospitalization, which resulted in significant cost-savings of up to £990 per patient. The findings suggest that this model could be replicated across other NHS trusts, and could lead to improved care delivery, improved patient experience and shorter inpatient stay. |
2023 |
This study compared procedural and outcome data for PFA-PVI to VHPSD-PVI in patients with paroxysmal or persistent atrial fibrillation (PAF/persAF). |
Pulsed-field ablation and VHPSD-PVI seem to be highly effective and safe to achieve PVI in the setting of PAF and persAF with comparable arrhythmia-free survival. However, procedure duration for PFA PVI is significantly shorter and therefore may be of potential benefit. Compared to PFA VHPSD-PVI might ensure information on left atrial substrate allowing to target concomitant secondary tachycardias. |
|
2023 | To test the feasibility of postprocedural photoplethysmography (PPG) rhythm telemonitoring during the first week after atrial fibrillation (AF) ablation and its predictive value for later AF recurrence. |
PPG rhythm telemonitoring during the first week after AF ablation often triggered clinical interventions. Due to its high availability, PPG-based follow-up actively involving patients after AF ablation may close a diagnostic and prognostic gap in the blanking period and increase active patient-involvement. |
|
Changes in healthcare utilisation and declarable care products during the implementation of a remote atrial fibrillation management pathway: The TeleCheck-AF project | 2023 | To evaluate changes in healthcare utilisation and declarable care products during the implementation of the TeleCheck-AF approach in a Dutch AF-clinic. |
The implementation of TeleCheck-AF was associated with a change in health care utilisation which resulted in a disproportional drop in reimbursement by health insurances due to a shift in declarable care products weights. Results of this analysis were basis to design a new reimbursement code for the TeleCheck-AF approach in the Netherlands. |
2023 |
The current sub-study of the TeleCheck-AF project aimed to provide the first real-world dataset on feasibility and patient experience of this standardized mobile health (mHealth) infrastructure in the clinical setting of follow-up after catheter ablation. |
The TeleCheck-AF approach is feasible and associated with high adherence as well as motivation to use the app and with optimal patient experience. Whether this approach can replace conventional rhythm follow-up after catheter ablation required further study. |
|
Photoplethysmography telemonitoring during the first week after atrial fibrillation ablation: Feasibility and clinical implications | 2022 | To assess the feasibility and clinical implications of PPG telemonitoring specifically during the first week after atrial fibrillation ablation is unknown. | Rhythm monitoring with a PPG-based mHealth application was feasible and often resulted in clinical interventions. Due to its high availability, PPG-based follow-up actively involving patients after AF ablation may close a diagnostic and prognostic gap and increase active patient-involvement |
Mobile app-based symptom-rhythm correlation assessment in patients with persistent atrial fibrillation | 2022 | To introduce a novel mobile app-based simultaneous symptom and rhythm monitoring approach to assess symptom-rhythm correlation in patients with persistent AF | In persistent AF patients, simultaneous mobile app-based symptom and rhythm monitoring revealed a relatively low overall SRC, which was mainly driven by a majority of AF recordings which were asymptomatic. Extrasystoles can explain a minority of symptomatic non-AF PPG recordings. Pulse rate, but not pulse variability, is the main determinant of reported symptoms during AF and non-AF PPG recordings. Further studies are required to test whether mobile app-based SRC assessment can be implemented in current workflows and integrated into a personalized symptom and rhythm control AF management approach. |
On-Demand Mobile Health Infrastructure for Remote Rhythm Monitoring within a Wait-and-See Strategy for Recent-Onset Atrial Fibrillation- TeleWAS-AF | 2021 | To describe the implementation of the TeleWAS-AF approach, an on-demand mHealth-based heart rate and rhythm monitoring infrastructure to support a WAS strategy for patients presenting with recent-onset AF at the ED | While maintaining the delivery of comprehensive treatment, the approach has a potential to reduce the burden on EDs and enhance the capacity for health-care utilization. However, given the change in the treatment approach, redesign of care delivery and reimbursement models may be warranted. Obviously, patients’ role in the decision-making process and the communication between patients and the treatment team is crucial. This approach will be implemented in all participating centers of the TeleCheckAF project |
Impact of photoplethysmography on therapeutic decisions in atrial fibrillation | 2021 | Rapid identification and implementation of remote healthcare delivery methods in time of COVID-19 pandemic. Three months after discharge, and therefore after blanking period, the patient was included in a novel pan-European project TeleCheck-AF, designed to facilitate the remote management of patients with AF | This case highlights the feasibility of PPG applications in monitoring patients after ablation and shows how the results can be used to guide and inform further therapeutic decisions. Whether PPG technology can be used as routine rhythm monitoring for the follow-up after AF ablation warrants further study |
Post-ablation outcome monitoring using a pulse-deriving smartphone application | 2018 | To investigate whether the implementation of a pulse-deriving smartphone application in this population offers the potential to detect early as well as late recurrence in order to initiate proper treatment in a timely manner. | Pulse-deriving smartphone applications implemented in combination with a structured care path proved to be a promising methodology for short-and long-term outcome monitoring of post-ablation patients and are capable in the detection of silent intermittent atrial fibrillation episodes. |
FibriCheck PPG readability
Title | Year | Objective | Key message(s) |
---|---|---|---|
Accuracy of Physicians Interpreting Photoplethysmography and Electrocardiography Tracings to Detect Atrial Fibrillation: INTERPRET-AF | 2021 | To compare the performance of physicians to detect atrial fibrillation (AF) based on photoplethysmography (PPG), single-lead ECG and 12-lead ECG, and to explore the incremental value of PPG presentation as a RR tachogram and poincaré plot, and of algorithm classification for interpretation by physicians. | Physicians can detect AF on a PPG output with equivalent accuracy compared to single-lead ECG in high-quality recordings. A RR tachogram and poincaré plot should be provided to facilitate the interpretation of the PPG waveform. The accuracy did not further improve, when the physicians were provided with the FibriCheck algorithm results in addition to the PPG waveform with plots. It remains that 12-lead ECG is more specific, and thus results in a higher positive predictive value and fewer false positives. |
Interpretation of photoplethysmography: a step-by-step guide | 2021 | - | - |
The accuracy of physician interpretation of PPG vs single-lead ECG vs 12-lead ECG for the detection of atrial fibrillation | 2021 | To study the performance of physicians to detect AF based on PPG vs single-lead ECG vs 12-lead ECG, and to explore the incremental value of a RR tachogram, poincaré plot, and algorithm output to the interpretation of the PPG waveform by physicians | Qualitative analysis of a PPG waveform with RR tachogram and poincaré plot had a similar diagnostic performance to detect AF compared to single-lead ECG analysis and a similar sensitivity but lower specificity compared to 12-lead ECG. PPG rhythm recordings, analyzed by physicians as a waveform in combination with the corresponding RR tachogram and poincaré plot, achieve similar diagnostic accuracy as single-lead ECG to detect AF. |
The photoplethysmography dictionary-practical guidance on signal interpretation and clinical scenarios from TeleCheck-AF | 2021 | To develop an educational structured stepwise practical guide on how to interpret PPG signals and to study typical clinical scenarios how on-demand PPG was used in the TeleCheck-AF project. | Introducing a newly developed structured stepwise practical guide on PPG signal interpretation developed based on presented experiences from TeleCheck-AF. The present clinical scenarios for the use of on-demand PPG technology derived from the TeleCheck-AF project will help to implement PPG technology in the management of arrhythmia patients. |
The photoplethysmography dictionary-practical guidance on signal interpretation and clinical scenarios from TeleCheck-AF | 2021 | This PPG dictionary aims to provide an overview on PPG technology and describe an educational structured stepwise practical guide on how to analyze and interpret PPG signals recorded within the TeleCheck-AF project. By introducing clinical scenarios where the use of on-demand app-based PPG heart rate and rhythm monitoring can be of clinical benefit and presenting several representative PPG recordings, the task of this manuscript also covers the creation of an educational tool and support to implement PPG technology in clinical practice. | Combining the PPG raw data with the RR tachogram and poincaré plot may improve the readability of PPG recordings. A physician’s own interpretation of the record together with the knowledge of the patient's medical history can improve the diagnosis and even extend it to arrhythmias other than AF. On-demand mHealth combined with teleconsultation is feasible and was received positively by both physicians and patients. Reduced risk of rehospitalization and clinical adverse events was previously demonstrated for an integrated AF care approach supported by mHealth. However, clinical outcomes have not been evaluated in the TeleCheck-AF project, yet. Accelerated through the COVID-19 pandemic and the initiation of the TeleCheck-AF project, more and more centers in Europe have been using PPG technology on-demand around teleconsultations to allow remote heart rate and rhythm assessment of consulted patients. |
Atrial Fibrillation Diagnosis Based on a Smartphone Derived PPG Waveform-A Diagnostic Accuracy Study versus Single-Lead | 2018 | To determine the ability of AF vs. non-AF diagnosis based on the visual interpretation of a PPG signal vs. a single-lead ECG-signal | The use of a PPG-based smartphone application for AF diagnosis resulted in a relatively high accuracy compared to single-lead ECG, although a significant difference was observed. After data-analysis, solely high-quality became non-significant. This stresses the importance to focus on algorithms that improve the quality or to detect impaired quality issues related to the signal. |
Usability
Title | Year | Objective | Key Message(s) |
---|---|---|---|
Patient motivation and adherence to an on-demand app-based heart rate and rhythm monitoring for atrial fibrillation management: data from the TeleCheck-AF project | 2022 | To evaluate motivation and adherence to on-demand heart rate/rhythm monitoring app in patients with atrial fibrillation (AF). | The overall adherence to this mHealth application was high, with a mean adherence of 94% and a motivation of 67%. Higher age and absence of diabetes are independent predictors for patient motivation and adherence to instructions Physicians, nurses, and allied health specialists involved in the management and care for patients with AF should not be discouraged to provide a mHealth infrastructure to elderly patients. Other predictors of mHealth adherence in TeleCheck-AF were the female sex and previous AF ablation (adherence). |
Patient motivation and adherence to an on-demand app-based heart rate and rhythm monitoring infrastructure for atrial fibrillation management through teleconsultation. TeleCheck-AF project results | 2022 | To provide the first real-world dataset on patient adherence and motivation to a standardized mHealth application integrated in remote AF management. | Older age and diabetes were predictors of optimal patient motivation and adherence to app-based heart rate/rhythm monitoring. Physicians, nurses and allied health specialists involved in the management and care for patients with AF should not be discouraged to provide a mHealth infrastructure to elderly patients. Patient engagement improves mHealth adherence/motivation, hence, it is crucial to tailor the mHelath intervention to the needs and preferences of the patient. |
A Heart Rate Monitoring App (FibriCheck) for Atrial Fibrillation in General Practice - Pilot Usability Study | 2021 | To assess whether the introduction of an app like Fibricheck is feasible and to study its efficacy as a diagnostic tool to facilitate screening. This pilot study aimed to assess the ease of use and implementation of the FibriCheck app | Fibricheck has a high measurement compliance, with most participants finding the app easy to use. The user experience was positive, and most participants agreed the app gave them a feeling of reassurance and could benefit their doctor–patient relationship. Despite the older age and limitations in use of modern technology and smartphones, most participants in the study had no problems using the FibriCheck app. Cost–benefit issues and potential barriers to large-scale implementation have yet to be identified. |
Remote app-based management of atrial fibrillation during the COVID-19: The centre characteristics and experiences of the European TeleCheck-AF project | 2021 | To describe the characteristics, inclusion rates and experiences from participating centres in the European TeleCheck-AF project. | Despite different health care settings and mHealth experiences, the TeleCheck-AF approach could be set up within an extremely short time and easily used in different European centers during COVID-19. |
The European TeleCheck-AF project on remote app-based management of atrial fibrillation during the COVID-19 pandemic - centre and patient experiencesThe European TeleCheck-AF project on remote app-based management of atrial fibrillation during the COVID-19 pandemic - centre and patient experiences | 2021 | To describe the characteristics of participating centers in the TeleCheck-AF project and to discuss the patient inclusion rate and use of the mHealth infrastructure in the context of center characteristics and the policy restrictions related to the COVID-19 pandemic in each corresponding country. In addition, we describe center and patient experiences regarding the TeleCheck-AF infrastructure and self-reported characteristics of recruited patients. | Despite the standardized instruction of all centers, the temporal enrolment pattern of patients varied in the different country groups. Factors such as experiences with mHealth solutions, older software systems in some hospital sites and the indication and motivation to perform heart rate and rhythm monitoring may have contributed to this observation. Inclusion rates were highest during the lockdown restrictions (until Week 7) and reached a steady state at a lower level after easing the restrictions. Differences in patient mHealth experience might have impacted the implementation process of the TeleCheck-AF approach. More than half of the patients with a PPG detected AF episode by FibriCheck were asymptomatic and just 65.4% of all symptom-triggered events were associated with PPG recordings suggestive for AF. |
The TeleCheck-AF project on remote app-based management of atrial fibrillation during the COVID-19 pandemic: Patient experiences | 2021 | To describe the characteristics and experiences from recruited patients in the Fibricheck-app. | Patients agreed that the FibriCheck® app was easy to use (94%) and easy to install (89%). The app gave patients a safe feeling (74%) due to being in constant heart rate and rhythm control. More than half of the patients (58%) agreed or strongly agreed that they would like to use the FibriCheck® app in the future. They also found the automated reminders useful (64%). Patients think that remote rate and rhythm monitoring around teleconsultation by the TeleCheck-AF approach may be an alternative to traditional face-to-face consultations in the future. |
Effect of age on the usability of a photoplethysmography based smartphone application | 2019 | This work investigates the effect of age on the usability of a PPG based smartphone application. | Although there is a difference in time to perform tasks and in the difficulty experienced between age categories, it does not affect the usability of the smartphone application. These results demonstrate that the relevant target groups can be reached when using a smartphone application as a screening device |
The quality of smartphone based heart rhythm monitoring using PPG technology in a large-scale free-living setting | 2019 | This observational study evaluated the applicability and robustness of a pulse deriving smartphone application implemented in a broad population in a free living setting. | The frequency of insufficient measurements decreased over the period of the study. Participants who only performed high quality PPG measurements were significantly younger compared to participants with at least one insufficient quality measurement. These results indicate the potential of a pulse deriving smartphone application to detect atrial fibrillation. |
Remote app-based management of atrial fibrillation during the COVID-19: The centre characteristics and experiences of the European TeleCheck-AF project | 2021 | To describe the characteristics, inclusion rates and experiences from participating centres in the European TeleCheck-AF project. |
Despite different health care settings and mHealth experiences, the TeleCheck-AF approach could be set up within an extremely short time and easily used in different European centers during COVID-19. |
Other
Title
|
Year | Objective | Key Message(s) |
---|---|---|---|
2023 |
To (1) analyze the SoMe Twitter network behind #TeleCheckAF, (2) describe the communities and behavioral groups within the network and (3) to determine the opinion leaders and influencers. |
The SoMe network behind #TeleCheckAF showed a wide dissemination involving a broad spectrum of healthcare professionals and was accelerated by the official ESC Twitter handles. Social network analysis created a helpful insight into the mechanisms behind innovation dissemination within social media. Future research could further analyze the difssemination process using e.g. hazard modeling and investigate the evolution of the network and behaviors over time. |
|
How to use digital devices to detect and manage arrhythmias: an EHRA practical guide | 2022 |
The aim of the document is to provide up-to-date practical guidance on the use of digital devices for arrhythmias, from early detection through management and implementation, using the categories of consensus. |
Overall digital devices for heart rhythm monitoring are abundant, and with the rapid advancement of technologies likely to increase further. In the future, a digital workflow will likely be implemented at most cardiology clinics, and the devices available will likely have additional monitoring capabilities and features. |
Mobile Health zur Detektion von Vorhofflimmern – Status quo und Perspektiven
|
2022 | - | - |
2022 | To summarize technical aspects and clinical purposes of DiHA for the detection of AFib. | There is ample evidence pointing to high accuracy of DiHA for the detection of AFib (analytical validation). While ECG-based algorithms often require additional sensors, PPG utilizes techniques integrated in smartphones or smartwatches. The advantage for clinical use results from the widespread accessibility for rhythm monitoring, allowing for earlier diagnosis and higher detection rates of AFib. Most available studies indicate a benefit for the use of DiHA.However, the evidence regarding hard clinical endpoints and positive care effects (clinical validation) still requires improvement. |
|
2021 ISHNE/ HRS/ EHRA/ APHRS collaborative statement on mHealth in Arrhythmia Management Digital Medical Tools for Heart Rhythm Professionals
|
2021 | To describe the current status of mobile health technologies in arrhythmia management. | Several key characteristics of AF can be measured with long-term continuous or near-continuous monitoring, and the information gained may provide valuable information for patient management. mHealth extends AF screening to younger patients without cardiovascular disease, and thrombo-embolic potential may be low. |
2021 | To determine the several aspects of AF-screening (why, theoretical approach of strategies, who, how, duration, intensity, pitfalls and future). | AF detection rate of screening is determined by the population, the tool, the frequency, and the duration of screening. In general, longer and more frequent screening in a population at higher risk for AF results in a higher detection rate. Implantable cardiac rhythm devices have the highest AF detection rates. Single-lead ECG and PPG devices are potentially more cost-effective and are more convenient for population-wide screening |
|
2021 | To systematically review the available literature on mobile Health (mHealth) solutions, including handheld and wearable devices, implantable loop recorders (ILRs), as well as mobile platforms and support systems in atrial fibrillation (AF) detection and management | There is already some data demonstrating that PPG technology is nearly as accurate as ECG to detect AF. The studies which used randomly selected, mostly, low-risk populations, reported the lowest accuracy for AF detection, whereas those focused on AF screening among high-risk and/or elderly populations, reported the highest sensitivity and specificity for AF detection. More targeted population selection and identifying those patients at higher risk of AF by using specific biomarkers is a reasonable way to boost the pre-test, hence reduce false-positive results, especially among populations that are not represented by the usual risk scores (especially CHADS2 and CHA2DS2-VASc). |
|
2020 | To determine the accuracy of smartphone camera applications that diagnose and screen for AF and to determine which application is the most accurate. | All smartphone camera applications individually had a high sensitivity and specificity, and this remained true for the meta-analyzed estimate for all applications collectively. It would be interesting to examine whether the PPV would improve if these applications were used to screen a further selective high-risk population, for instance among patients with a CHA2DS2-VASc score of at least 3, those at high genetic risk or with chronic AF. There seemed to be 3 clinical situations in which these applications could be used (or are currently being used), as follows: as a screening tool, as a diagnostic test, and/or as a monitoring device. It remains unclear whether patients with AF uncovered via screening would benefit from receiving anticoagulation medication. |
|
2020 | To conduct a systematic review of the literature (43 studies) and summarize the performance of mHealth devices in diagnosing and screening for AF. | The performance of mHealth devices in detecting AF depends on the characteristics of the population being studied, their risk of developing AF, and the technology used to detect AF. The lower specificity achieved by PPG algorithm in comparison to AliveCor algorithms may be explained by finger movement artifacts that can affect the detection algorithm, leading to a reduction in specificity when the smartphone application is used outside the clinic. Pulse palpation can result in greater false-positive cases by falsely assigning a diagnosis of AF to patients with transient pulse irregularities. The use of 12-lead ECG for screening purposes is limited by its lack of portability and holters have a high cost. Mobile health devices offer a feasible option for mass screening of AF in diverse settings as they are user-friendly, leadless, and widely used by the general population. |
|
2020 | Explaining the coordination of the TeleCheck-AF approach and the implementation of this mHealth intervention in European centers. | The TeleCheck-AF approach was a significant source of support and reassurance for both patients and health care providers. Coordination appeared to be a key concept, intertwined with numerous aspects of the mHealth infrastructure: from empowering patients to self-manage the on-demand application, to implementation of the approach in clinical centers, aiming to strengthen the health system response toCOVID-19. |
|
2020 | - | TeleCheck-AF is a user-friendly and short intervention that puts the patient ‘in charge’ of their care by delivering vital data which may also result in better adherence to the treatment regime. The data provided by the patient are stored in a cloud, are easily accessible and provides the healthcare professional with an overview of heart rhythm and rate as well as whether the patient has experienced AF-related symptoms. |
|
2020 | To describe the components and implementation of the TeleCheck-AF approach in an integrated and specialized AF-clinic through teleconsultation during COVID-19. | The patient is actively involved in the treatment trajectory by monitoring heart rate and rhythm information, as well as blood pressure and weight measures. Education about AF management and the importance of lifestyle and risk factor management is provided. The app is a true example of mHealth impacting both the patient as well as the health care professional. During COVID-19, remote adaptation of rate and rhythm medication guided by the on-demand monitoring infrastructure are elemental parts of TeleCheck-AF. |
|
2020 | To monitor rate and rhythm remotely just around teleconsultations to allow a better assessment of the dis-ease state of the patient and to support treatment decisions. This on-demand approach was regulated by a prescription to use the app for a limited predefined time period, which avoids unnecessary data-load and additional follow-up patients-contacts. | The relatively low cost, convenience, and broad accessibility of the mobile phone app used in this approach allows a fast and broad implementation of the described mHealth infrastructure during the COVID-19 pandemic. A potential disadvantage is that no electrocardiogram is provided. It is feasible to implement a novel app-based on-demand rhythm and rate monitoring infrastructure to efficiently provide teleconsultations in an AF population. |
|
2020 | To discuss mobile health (mHealth) tools and strategies to remotely monitor heart rate and rhythm and incorporate AF risk factors assessment to allow comprehensive AF management through teleconsultation. Additionally, as a possible solution to improve remote AF care during the COVID-19 pandemic, the on-demand TeleCheck-AF mHealth approach allows remote app-based assessment of heart rate and rhythm around teleconsultations | During the COVID-19 pandemic there is decreased capacity to see patients in the outpatient clinic and mHealth has become an important component of many AF outpatient clinics. mHealth technologies can be used for (semi-)continuous longitudinal monitoring or for short-term on-demand monitoring, depending on the respective requirements and clinical scenarios. Large scale international mHealth projects, such as TeleCheck-AF, will provide insight into the additional value and potential limitations of mHealth strategies to remotely manage AF patients. Such mHealth infrastructures may be well suited within an integrated AF-clinic, which may require redesign of practice and reform of health care systems. |
|
2020 | To inform about Telecheck-AF and the progress of the TeleCheck-AF project during the COVID-19 pandemic and to invite other centres to participate. | To guarantee the continuity of comprehensive AF management through teleconsultation during COVID-19, a mobile health (mHealth) intervention was developed at the university of Maastricht. An mHealth prescription (QR-code) activates the app and links the app toa secure cloud accessible by the treating physician. The primary focus of the project is to maintain AF management while keeping patients out of hospital during COVID-19. Since the launch of the project, 23 European hospitals across nine countries have joined the project |
|
2020 | To define the specific data required for physicians to make clinical decisions by conducting a second survey. To define data quality required to take clinical decisions based on wearable device recordings and which data is important. To describe actual handling of these technologies in the context of current guidelines and identify gaps in current evidence to delineate the need for future guideline recommendations. To evaluate how the COVID-19 pandemic influenced the use of wearable devices and teleconsultations. | The study demonstrated that physicians: would diagnose AF and take therapeutic steps based on a single-lead ECG state that wearable rhythm-device ECG technology is suitable for AF screening, arrhythmia diagnostics, and patient monitoring, believe in the large potential of AI for the future of AF diagnostics and clinical decision making regarding oral anticoagulation point out that there is lack of reimbursement or information about reimbursement when dealing with wearable device rhythm recordings believe that costs for wearable rhythm devices should be shared between patients and the health insurer or government believe that teleconsultations in the future will remain at the same level as during the COVID-19 pandemic |
|
2020 | To assess impact of these technologies on physicians' clinical decision-making regarding initiation of diagnostic steps, drug therapy, and invasive strategies. | Most physicians would consider a wearable device recording sufficient to start anticoagulation. Although sensitivity and specificity of PPG tracings are comparable to single-lead ECGs, physicians would rather make clinical decisions based on single-lead ECGs. Physicians also would be more reluctant to prescribe anticoagulation in asymptomatic patients, although stroke risk in patients with AF is not linked to symptoms of AF. Further studies and consensus is required on when and whom to anticoagulate based on wearable device rhythm recordings. |
|
2020 | To generate insights into current practices and opinions of healthcare practitioners (HCPs) regarding using digital devices for AF management |
Cardiac electrophysiologists were more likely to have recommended the use of a digital device compared to other HCPs, and those in private practice were more likely to do so than practitioners in university hospital settings. |
Comments
0 comments
Article is closed for comments.